Related Experiment Videos
Cancer immunotherapy with chemoattractant peptides
1Laboratorio di Ematologia Oncologica, Divisione di Ematologia dell'Universita' di Torino, CeRMS, Azienda Ospedaliera San Giovanni Battista, Torino, Italy.
Seminars in Cancer Biology
|July 13, 2004
Summary
The chemokine network regulates immune surveillance and cancer progression. Harnessing chemokines offers new therapeutic strategies for cancer immunotherapy by modulating immune cells and tumor growth.
Area of Science:
- Immunology
- Oncology
- Molecular Biology
Background:
- The chemokine/chemokine receptor network is integral to immune surveillance and homeostasis.
- This network influences neovascularization, tumor growth, and metastasis.
- Existing research aims to leverage chemokines for cancer therapeutics.
Purpose of the Study:
- To explore the therapeutic potential of the chemokine network in cancer treatment.
- To investigate methods for rebalancing chemokines to control angiogenesis and tumor metastasis.
- To understand the role of chemokines in eliciting antitumor immunity.
Main Methods:
- Review of existing studies on chemokine-based cancer therapies.
- Analysis of how chemokines modulate immune cell subsets, including antigen-presenting cells.
- Examination of second-generation immunotherapeutics and chemoattractant-based vaccines.
Main Results:
- Chemokines play a dual role in promoting or suppressing neovascularization.
- The chemokine network directly and indirectly impacts malignant cell growth and metastasis.
- Chemokines and chemoattractant peptides are utilized in novel immunotherapies.
Conclusions:
- Targeting the chemokine network is a promising strategy for cancer treatment.
- Modulating chemokine balance can control tumor angiogenesis and metastasis.
- Chemokine-based vaccines can elicit specific antitumor immune responses.